HOUSTON (AP) _ Aravive, Inc. (ARAV) on Thursday reported a loss of $13 million in its fourth quarter.The Houston-based company said it had a loss of 62 cents per share.The biopharmaceutical company posted revenue of $985,000 in the period, falling short of Street forecasts. Three analysts surveyed by Zacks expected $1.6 million.For the year, the company reported that its loss widened to $39.2 million, or $1.95 per share. Revenue was reported as $7.4 million.In the final minutes of trading on Thursday, the companyâ€™s shares hit $1.93. A year ago, they were trading at $6.59._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARAV at https://www.zacks.com/ap/ARAV